Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 11, 2013
Trevigen Inc. has been awarded $252,000 for the Small Business Innovation Research (SBIR) Phase I Contract, 261201300042C, from the National Cancer Institute and the National Institutes of Health (NIH) to develop a tumor-aligned 3D coculture system. ...
read more
Wednesday, December 11, 2013
PharmSource, the acknowledged authority on bio/pharmaceutical contract manufacturing, has released an extensive
study on the supply and demand for contract injectable manufacturing through 2019. This important analysis
provides invaluable ...
read more
Friday, December 13, 2013
Thomas Feinberg, PhD, Catalent Pharma Solutions’ Director of Development and Analytical Solutions, is to present at the forthcoming “Suitability and Compatibility for Packaging and Delivery Systems
read more
Friday, December 13, 2013
The American Association of Pharmaceutical Scientists (AAPS) has established a premier information network for pharmaceutical scientists around the world. In order to have a greater impact in advancing the contributions of the pharmaceutical sciences...
read more
Friday, December 13, 2013
Pharmalucence, Inc. (www.pharmalucence.com) today announced that it has entered into an agreement with Lantheus Medical Imaging, Inc. (www.lantheus.com) to serve as a contract manufacturer of DEFINITY® Vial for (Perflutren Lipid Microsphere) ...
read more
Friday, December 13, 2013
Leading events organiser, UBM Live announces that CPhI Japan is returning for its twelfth year to Tokyo, from the 9th to the 11th April, 2014. The event will once again be co-locating to provide an all-round experience, creating a pivotal meeting-...
read more
Friday, December 13, 2013
Almac‘s Enzyme Research and Development team have been recognised at The Irish Laboratory Awards by winning “Laboratory Team of the Year.”
read more
Friday, December 13, 2013
Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services (CRS) business stream serving the Japanese chemical, agrochemical and pharmaceutical markets.
read more
Friday, December 20, 2013
In his new role, Ross is responsible for managing and expanding Metrics’ fee-for-service operations. The company’s comprehensive contract services include pharmaceutical oral dose formulation development with dedicated suites for potent product ...
read more
Friday, December 20, 2013
Temptime Corporation, the world’s leading
provider of time-temperature indicators to the health care industry, announced today that it
has acquired Enfield, Conn.-based William Laboratories to expand into blood temperature
monitoring solutions. ...
read more
Friday, December 20, 2013
CMC Biologics and OncoSynergy announced today that the two
companies entered into an agreement for cell-line development, process development,
analytical development and manufacturing of non-GMP material to enable early toxicology
testing and cGMP...
read more
Friday, December 20, 2013
FlowMetric, a market leader in flow cytometry and cell sorting services, announced today that they have hired Rachel A. Bunting to lead their Business Development Unit. Ms. Bunting will be tasked with overseeing a rapidly expanding portfolio of ...
read more
Friday, December 20, 2013
Celerion is proud to announce the 80th anniversary of operations at our first facility in Lincoln, Nebraska. Celerion is at the forefront of early clinical research with corporate headquarters in Lincoln, plus seven other facilities globally ...
read more
Friday, December 20, 2013
Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the ...
read more
Friday, December 20, 2013
The European Medicines Agency (EMA) has now reviewed all comments received on its draft policy on publication and access to clinical trial data. While the comments received showed that there is large support for the Agency’s plans to allow access to ...
read more